Cargando…
Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery?
Background: The use of therapeutic antibodies for the treatment of neurological diseases is of increasing interest. Nose-to-brain drug delivery is one strategy to bypass the blood brain barrier. The neonatal Fc receptor (FcRn) plays an important role in transepithelial transcytosis of immunoglobulin...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161100/ https://www.ncbi.nlm.nih.gov/pubmed/30050027 http://dx.doi.org/10.3390/pharmaceutics10030107 |
_version_ | 1783358916861624320 |
---|---|
author | Ladel, Simone Flamm, Johannes Zadeh, Arghavan Soleimani Filzwieser, Dorothea Walter, Julia-Christina Schlossbauer, Patrick Kinscherf, Ralf Lischka, Katharina Luksch, Harald Schindowski, Katharina |
author_facet | Ladel, Simone Flamm, Johannes Zadeh, Arghavan Soleimani Filzwieser, Dorothea Walter, Julia-Christina Schlossbauer, Patrick Kinscherf, Ralf Lischka, Katharina Luksch, Harald Schindowski, Katharina |
author_sort | Ladel, Simone |
collection | PubMed |
description | Background: The use of therapeutic antibodies for the treatment of neurological diseases is of increasing interest. Nose-to-brain drug delivery is one strategy to bypass the blood brain barrier. The neonatal Fc receptor (FcRn) plays an important role in transepithelial transcytosis of immunoglobulin G (IgG). Recently, the presence of the FcRn was observed in nasal respiratory mucosa. The aim of the present study was to determine the presence of functional FcRn in olfactory mucosa and to evaluate its role in drug delivery. Methods: Immunoreactivity and messenger RNA (mRNA) expression of FcRn was determined in ex vivo porcine olfactory mucosa. Uptake of IgG was performed in a side-by-side cell and analysed by immunofluorescence. Results: FcRn was found in epithelial and basal cells of the olfactory epithelium as well as in glands, cavernous bodies and blood vessels. Allogenic porcine IgGs were found time-dependently in the lamina propria and along axonal bundles, while only small amounts of xenogenic human IgGs were detected. Interestingly, lymphoid follicles were spared from allogenic IgGs. Conclusion: Fc-mediated transport of IgG across the nasal epithelial barrier may have significant potential for intranasal delivery, but the relevance of immune interaction in lymphoid follicles must be clarified to avoid immunogenicity. |
format | Online Article Text |
id | pubmed-6161100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61611002018-10-01 Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery? Ladel, Simone Flamm, Johannes Zadeh, Arghavan Soleimani Filzwieser, Dorothea Walter, Julia-Christina Schlossbauer, Patrick Kinscherf, Ralf Lischka, Katharina Luksch, Harald Schindowski, Katharina Pharmaceutics Article Background: The use of therapeutic antibodies for the treatment of neurological diseases is of increasing interest. Nose-to-brain drug delivery is one strategy to bypass the blood brain barrier. The neonatal Fc receptor (FcRn) plays an important role in transepithelial transcytosis of immunoglobulin G (IgG). Recently, the presence of the FcRn was observed in nasal respiratory mucosa. The aim of the present study was to determine the presence of functional FcRn in olfactory mucosa and to evaluate its role in drug delivery. Methods: Immunoreactivity and messenger RNA (mRNA) expression of FcRn was determined in ex vivo porcine olfactory mucosa. Uptake of IgG was performed in a side-by-side cell and analysed by immunofluorescence. Results: FcRn was found in epithelial and basal cells of the olfactory epithelium as well as in glands, cavernous bodies and blood vessels. Allogenic porcine IgGs were found time-dependently in the lamina propria and along axonal bundles, while only small amounts of xenogenic human IgGs were detected. Interestingly, lymphoid follicles were spared from allogenic IgGs. Conclusion: Fc-mediated transport of IgG across the nasal epithelial barrier may have significant potential for intranasal delivery, but the relevance of immune interaction in lymphoid follicles must be clarified to avoid immunogenicity. MDPI 2018-07-26 /pmc/articles/PMC6161100/ /pubmed/30050027 http://dx.doi.org/10.3390/pharmaceutics10030107 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ladel, Simone Flamm, Johannes Zadeh, Arghavan Soleimani Filzwieser, Dorothea Walter, Julia-Christina Schlossbauer, Patrick Kinscherf, Ralf Lischka, Katharina Luksch, Harald Schindowski, Katharina Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery? |
title | Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery? |
title_full | Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery? |
title_fullStr | Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery? |
title_full_unstemmed | Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery? |
title_short | Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery? |
title_sort | allogenic fc domain-facilitated uptake of igg in nasal lamina propria: friend or foe for intranasal cns delivery? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161100/ https://www.ncbi.nlm.nih.gov/pubmed/30050027 http://dx.doi.org/10.3390/pharmaceutics10030107 |
work_keys_str_mv | AT ladelsimone allogenicfcdomainfacilitateduptakeofigginnasallaminapropriafriendorfoeforintranasalcnsdelivery AT flammjohannes allogenicfcdomainfacilitateduptakeofigginnasallaminapropriafriendorfoeforintranasalcnsdelivery AT zadeharghavansoleimani allogenicfcdomainfacilitateduptakeofigginnasallaminapropriafriendorfoeforintranasalcnsdelivery AT filzwieserdorothea allogenicfcdomainfacilitateduptakeofigginnasallaminapropriafriendorfoeforintranasalcnsdelivery AT walterjuliachristina allogenicfcdomainfacilitateduptakeofigginnasallaminapropriafriendorfoeforintranasalcnsdelivery AT schlossbauerpatrick allogenicfcdomainfacilitateduptakeofigginnasallaminapropriafriendorfoeforintranasalcnsdelivery AT kinscherfralf allogenicfcdomainfacilitateduptakeofigginnasallaminapropriafriendorfoeforintranasalcnsdelivery AT lischkakatharina allogenicfcdomainfacilitateduptakeofigginnasallaminapropriafriendorfoeforintranasalcnsdelivery AT lukschharald allogenicfcdomainfacilitateduptakeofigginnasallaminapropriafriendorfoeforintranasalcnsdelivery AT schindowskikatharina allogenicfcdomainfacilitateduptakeofigginnasallaminapropriafriendorfoeforintranasalcnsdelivery |